LOINCActiveOrder

LOINC Code 77175-8: C. burnetii phase 1 and 2 IgG and IgM panel (S)

77175-8 is a LOINC code used to identify C. burnetii phase 1 and 2 IgG and IgM panel (S) in laboratory and clinical observation data. You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges. LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Coxiella burnetii phase 1 & 2 Ab.IgG & IgM panel. It is commonly used with the system or sample type Ser.

Reviewed by HealthAssure Clinical TeamUpdated 21 May 2026

What is this code?

LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Coxiella burnetii phase 1 & 2 Ab.IgG & IgM panel. It is commonly used with the system or sample type Ser.

When is it used?

  • Used in lab systems, EHRs, and clinical data exchange.
  • May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
  • Status: ACTIVE
  • Order vs observation: Order
  • Panel type: Panel

What it does not mean

  • The code identifies the observation or test, not the actual result.

Key facts

Coxiella burnetii phase 1 and 2 IgG and IgM panel - Serum
Coxiella burnetii phase 1 & 2 Ab.IgG & IgM panel
This panel combines assays for phase 1 and 2, IgG and IgM antibody testing, for diagnosing past and present Q fever infections caused by Coxiella burnetii. Coxiella burnetii is a species of intracellular, pathogenic bacteria, and is the causative agent of Q fever. The genus Coxiella is morphologically similar to the rickettsia, but with a variety of genetic and physiological differences. C. burnetii are small Gram negative bacteria with two growth phases, as well as a spore form which lies idle in soil. It can survive standard disinfectants, and is resistant to many other environmental changes. PathogenesisThe ID50 (the dose need to infect 50% of experimental subjects) is one via inhalation i.e. inhalation of one organism will yield disease in 50% of the population. Disease occurs in two states: An acute state presents with headaches, chills, and respiratory symptoms, and an insidious chronic stage. While most infections clear up spontaneously, treatment with tetracycline appears to reduce the symptomatic duration and reduce the likelihood of chronic infection.
C burnet; C burnet Ph 1 + 2 IgG + IgM Pnl; C burnet Ph1; C burnet Ph1 + Ph2; C burnetii; Coxiella burnetii phase I; Coxiella burnettii; i; ID; II; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Q fev; Q fever; Qfever; QNT; Quan; Quant; Quantitative; Random; Rickettsial; Serum; SR

Where you may see this code

You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.

Common synonyms

C. burnetii phase 1 and 2 IgG and IgM panel (S)Coxiella burnetii phase 1 and 2 IgG and IgM panel - SerumC burnet Ph 1 + 2 IgG + IgM Pnl SerCoxiella burnetii phase 1 & 2 Ab.IgG & IgM panelPANEL.MICROCoxiella burnetii phase 1 and 2 IgG and IgM panel, Blood-

Frequently asked questions

Code details

Code77175-8
SystemLOINC
Display nameC. burnetii phase 1 and 2 IgG and IgM panel (S)
DescriptionCoxiella burnetii phase 1 & 2 Ab.IgG & IgM panel
Short nameC burnet Ph 1 + 2 IgG + IgM Pnl Ser
ComponentCoxiella burnetii phase 1 & 2 Ab.IgG & IgM panel
Property-
TimingPt
System (specimen)Ser
ScaleQn
ClassPANEL.MICRO
StatusACTIVE
Order/ObservationOrder

Flags

BillableNo
Valid clinical useNo

Source

SourceLOINC
Version2.82
Releasemain
First released2.52
Last changed2.56

Consumer names

Coxiella burnetii phase 1 and 2 IgG and IgM panel, Blood

Part names

Coxiella burnetii phase 1 & 2 Ab.IgG & IgM panel-PtSerQnCoxiella burnetii phase 1 and 2 IgG and IgM panelPoint in time (spot)Serum

About this content

This page is prepared by HealthAssure's clinical team using official coding standards from LOINC. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.

LOINC Code 77175-8 | HealthAssure